Navigation Links
Can Locoregionally Recurrent Breast Cancer Be Cured?
Date:4/13/2017

Arati Chand, M.D., physician for The Oncology Institute, has made instrumental contributions to the publication of Clinical Breast Cancer's article - Can Locregionally Recurrent Breast Cancer Be Cured? This publication will help other physicians and patients with the research and understanding of how to treat patients with locoregional breast cancer recurrence.

Advances in systemic therapy have had an impact on locoregional disease, and isolated LRRs of breast cancer are dropping in incidence.The biology of the disease is the most important factor in determining the recurrence risk of the individual cancer and the outcome for the patient. Patients who have LRR without systemic recurrence may benefit from multimodal therapy with curative intent. Tumor genomic profiling and next-generation sequencing may be important in clarifying individual tumor biology and identifying patients who will benefit from curative versus palliative therapy.

Abstract:

Locoregional recurrence (LRR) of breast cancer can occur after multidisciplinary treatment of a primary breast cancer.With modern multidisciplinary breast cancer treatment, the incidence of isolated LRR is decreasing. Improvements in systemic therapy are driving the decrease in LRR. LRR does still occur, however. LRR reflects biology of the cancer, as does systemic recurrence. LRR of breast cancer is frequently associated with systemic disease recurrence and poor prognosis. Given this associated poor prognosis, historically, it has been unclear whether patients with LRR would benefit from aggressive therapy with curative intent. Findings in retrospective studies suggest that prognosis for patients with LRR is not universally poor, and some patients may benefit from aggressive locoregional and systemic therapy. The challenge remains to assess prognosis and appropriately treat patients with locoregional breast cancer recurrence.

Arati Chand, M.D., M. Firdos Ziauddin, M.D., Shou-Ching Tang, M.D., Editors. Clinical Breast Cancer. Elsevier Inc. 2017.

Read the full story at http://www.prweb.com/releases/2017/04/prweb14205035.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related medicine news :

1. Fertility Associates of Memphis Physicians Selected to Lead National Recurrent Pregnancy Loss Discussion
2. Prodigy Sports Athletes – Competitive Figure Skaters Struggle With Recurrent Injuries
3. LA BioMed study finds daily antibiotics most effective in preventing recurrent urinary tract infection
4. Medication does not reduce risk of recurrent CV events among patients with diabetes
5. Renal denervation reduces recurrent AF after ablation
6. Adding cediranib to chemo improves progression-free survival for meta or recurrent cervical cancer
7. NEW APPROACH for Treatment of Recurrent Hamstring Strains and Hamstring Tendinosis is Available for the First Time in NYC
8. Robots from space lead to 1-stop breast cancer diagnosis treatment
9. Scientists at Cancer Prevention Institute of California Find That a Diet High in Fruits and Vegetables May Significantly Reduce Risk of Breast Cancer
10. Potential for added medical benefits uncovered for widely used breast cancer drug
11. UT Southwestern researchers discover a new driver of breast cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... 2017 , ... First Healthcare Compliance (FHC), an industry leader ... range of technology and learning solutions at the 68th Annual American Healthcare Association ... held October 14–18, 2017 at the Mandalay Bay Resort in Las Vegas, Nevada. ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... products to meet the demand of today’s consumer and regulatory authorities worldwide. From ... probiotic experts and tested to meet the highest standard. , These products ...
(Date:10/12/2017)... ... October 12, 2017 , ... Asante, a nationally recognized health ... expanded their existing home health joint venture through an agreement, effective October 1, ... joint venture home health company with Asante, delivering clinically integrated care, for the ...
(Date:10/12/2017)... Malvern, PA (PRWEB) , ... October 12, 2017 , ... ... is the recipient of a 2017 Folio Magazine Eddie Digital Award for ‘Best ... New York City on October 11, 2017. , The annual award competition recognizes editorial ...
(Date:10/12/2017)... ... October 12, 2017 , ... Women-owned and Grand ... Best and Brightest in Wellness® by Best and Brightest. OnSite Wellness will be ... Oct. 20 from 7:30 a.m. to 2 p.m. at the Henry Autograph Collection ...
Breaking Medicine News(10 mins):
(Date:10/5/2017)... Oct. 5, 2017  In response to the ... and Maxillofacial Surgeons (AAOMS) released prescribing recommendations that ... be used as a first-line therapy to manage ... Recognizing the value and ... Paper "Opioid Prescribing: Acute and Postoperative Pain Management" ...
(Date:10/4/2017)... the Centers for Disease Control and Prevention (CDC), influenza vaccination should ... helping communities across Massachusetts , Connecticut ... shots through the end of the month. *Some exclusions apply ... ... is by the end of October, according to the Centers for Disease ...
(Date:10/2/2017)... -- Diplomat Pharmacy, Inc. (NYSE: DPLO ) ... , and named its founder as Diplomat,s chief information ... Tennessee , will operate under Diplomat subsidiary Envoy ... for health care partners to include IT outsourcing, consulting, ... "In an interoperable world, technology delivers comprehensive insight and ...
Breaking Medicine Technology: